Leukemia, Prolymphocytic - 23 Studies Found
| Active, not recruiting |
: ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (Btk) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia :
|
| Completed |
: Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia : Leukemia : 2001-07-11 : Biological: alemtuzumab |
| Completed |
: Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) :
: 2005-08-02 :
|
| Active, not recruiting |
: Acalabrutinib in Combination With Obinutuzumab in Relapsed/Refractory or Untreated CLL/SLL/PLL :
|
| Completed |
: AZD6738 First Time in Patient Multiple Ascending Dose Study :
|
| Completed |
: Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias :
: 2007-05-11 :
|
| Completed |
: Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma :
: 2000-09-11 :
|
| Completed |
: Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL :
|
| Completed |
: A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) :
|